Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?

Buka Richard J.; Chandra Deepak; Sutton David J.

首页> 外文期刊>British Journal of Haematology >Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?

【24h】

Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?

机译：癌症不是一种疾病：将患有血液恶性肿瘤患者的癌症相关静脉血栓栓塞中直接口服抗凝剂的试验的推断是安全的，这是安全的患者是否安全？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Haematology》 |2021年第1期|共4页
作者
Buka Richard J.; Chandra Deepak; Sutton David J.;
展开▼
作者单位

Univ Hosp North Midlands Clin Haematol Stoke On Trent Staffs England;

Univ Birmingham Inst Immunol &

Immunotherapy Birmingham W Midlands England;

Univ Birmingham Inst Immunol &

Immunotherapy Birmingham W Midlands England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Superior safety of direct oral anticoagulants compared to Warfarin in patients with atrial fibrillation and underlying cancer: a national veterans affairs database study [J] . Abhishek C Sawant, Nidhi Kanwar, Aishwarya Bhardwaj, 老年心脏病学杂志（英文版） . 2019,第009期
2. Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats [J] . Casey OConnell, Carmen P. Escalante, Samuel Z. Goldhaber, The oncologist . 2021,第1期

机译：用低分子量肝素或直接口服抗凝血剂治疗癌症相关的静脉血栓栓塞：患者选择，争论和警告
3. Recurrent Venous Thromboembolism (VTE), Major Bleeding (MB), and Associated Cost of Treatment with Low Molecular Weight Heparin (LMWH) or Direct Oral Anticoagulant (DOAC) in High Risk Patients with Gastrointestinal (GI) Malignancies: Retrospective Real-World Analysis at a Comprehensive Cancer Center [J] . Boiles Alejandro Recio, McBride Ali, Babiker Hani M., Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：经常性的静脉血栓栓塞（VTE），具有低分子量肝素（LMWH）或高风险胃肠（GI）恶性肿瘤（GI）恶性肿瘤（LMWH）或直接口服抗凝血剂（DOAC）的相关成本：回顾性实际分析综合癌症中心
4. Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: New Insights from Randomized Controlled Trials [J] . Rojas-Hernandez Cristhiam M., Oo Thein Hlaing Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2019,第6期

机译：直接口服抗凝血剂在癌症患者的预防和治疗静脉血栓栓塞中：随机对照试验的新见解
5. Development and Assessment of RecosDoc-MTeV to Improve the Quality of Direct Oral Anticoagulant Prescription for Venous Thromboembolic Disease. [C] . Brigitte Séroussi, Houda Ouarrirh, Isma?l Elalamy, MEDINFO . 2019

机译：RecoSdoc-MTEV的开发和评估改善静脉血栓栓塞术治疗直接口服抗凝药物的质量。
6. Surveillance of Venous Thromboembolism in Oklahoma County: Using Multiple Surveillance Methods and Data Sources to Improve Case Identification and Description of VTE Disease among Patients with Cancer History [D] . McCumber, Micah Denay. 2020

机译：俄克拉荷马州静脉血栓栓塞监测：使用多种监测方法和数据来源来改善癌症历史患者患者患者疾病的案例鉴定及描述
7. Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm [O] . Justyna Domienik-Karłowicz, Miłosz Jaguszewski, Marcin Kurzyna 2020

机译：癌症相关静脉血栓栓塞中的直接口服抗凝血剂：它是治疗范式的变化的最佳时间
8. Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice [O] . Yutaka Ogino, Tomoaki Ishigami, Yugo Minamimoto, 2020

机译：常规临床实践中癌症相关静脉血栓栓塞的直接口服抗凝血治疗

Cancer is not a single disease: is it safe to extrapolate evidence from trials of direct oral anticoagulants in cancer-associated venous thromboembolism to patients with haematological malignancies?

著录项

相似文献

相关主题

期刊订阅